Iijima T, Shibuya M, Ito Y, Terauchi Y (2023) Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: a randomized controlled trial
Individual results may vary, and proper medical supervision is essential for safe medication management
Risks of Switching From Semaglutide to Tirzepatide Adverse Effects : Both medications may have commonly reported side effects which are generally gastrointestinal disturbances (nausea, vomiting, diarrhea, stomach upset) and injection-site reactions (1,2,4,5)
[5] [19] One of the physiological effects observed with retatrutide in Phase 2 trials is a modest reduction in systolic and diastolic blood pressure
Some employers and insurance plans now cover GLP-1 medications for obesity, but many do not
Always, always recalculate when you open a new vial